Gastrointestinal was Prestige Consumer Healthcare’s largest product and service line in fiscal 2025, bringing in $255.94M of $1.14B (22%).
| Product and Service | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Women's Health | $264.51M | $251.35M | $240.42M | $236.83M | |||||||||
| Gastrointestinal | $204.56M | $226.58M | $231.61M | $255.94M | |||||||||
| Eye & Ear Care | $163.45M | $171.08M | $179.42M | $183.32M | |||||||||
| Analgesics | $119.32M | $119.26M | $117.45M | $117.70M | |||||||||
| Cough & Cold | $107.08M | $126.99M | $119.02M | $106.21M | |||||||||
| Dermatologicals | $120.39M | $123.74M | $129.10M | $128.95M | |||||||||
| Oral Care | $97.52M | $97.63M | $96.31M | $95.03M | |||||||||
| Household Cleaning | — | — | — | — | |||||||||
| Other Otc | $9.99M | $11.10M | $12.03M | $13.78M | |||||||||
| Other Revenues | $42.00K | $107.00K | $311.00K | — | |||||||||
| Total | $1.09B | $1.13B | $1.13B | $1.14B |
Prestige Consumer Healthcare brought in $1.14B from its eight product and service lines in fiscal 2025, the year ended March 31, 2025. Prestige Consumer Healthcare regrouped these lines after fiscal 2024, so the total does not compare directly with that year's $1.13B. Gastrointestinal was the largest at $255.94M (22.5%), ahead of Women's Health at $236.83M (20.8%) and Eye & Ear Care at $183.32M (16.1%). The other five lines brought in $461.67M combined.
Compared with fiscal 2024, Gastrointestinal grew fastest, up 10.5% to $255.94M, while Cough & Cold fell the most, down 10.8% to $106.21M.
Prestige Consumer Healthcare stopped reporting Other Revenues as a separate line after fiscal 2024, when it brought in $311.00K.
North American Otc Healthcare was Prestige Consumer Healthcare’s largest segment in fiscal 2025, bringing in $960.01M of $1.14B (84%).
| Segment | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North American Otc Healthcare | $967.88M | $973.77M | $958.26M | $960.01M | |||||||||||
| Otc Healthcare | — | — | — | — | |||||||||||
| International Otc Healthcare | $118.93M | $153.95M | $167.10M | $177.75M | |||||||||||
| Household Cleaning | — | — | — | — | |||||||||||
| Total | $1.09B | $1.13B | $1.13B | $1.14B |
Prestige Consumer Healthcare brought in $1.14B from its two segments in fiscal 2025, the year ended March 31, 2025. That was up 1.1% from $1.13B in fiscal 2024. North American Otc Healthcare was the largest at $960.01M (84.4%), ahead of International Otc Healthcare at $177.75M (15.6%).
Compared with fiscal 2024, International Otc Healthcare grew 6.4% to $177.75M and North American Otc Healthcare grew 0.2% to $960.01M. From fiscal 2022 to 2025, combined revenue from these segments grew from $1.09B to $1.14B, a compound annual growth rate of 1.5%. North American Otc Healthcare's share of the total fell from 89.1% to 84.4%.
United States was Prestige Consumer Healthcare’s largest region in fiscal 2025, bringing in $897.54M of $1.14B (79%).
| Geography | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| United States | $910.11M | $953.22M | $886.47M | $897.54M | ||||||
| Rest Of World | $176.71M | $174.50M | $238.89M | $240.22M | ||||||
| Total | $1.09B | $1.13B | $1.13B | $1.14B |
Prestige Consumer Healthcare brought in $1.14B from its two regions in fiscal 2025, the year ended March 31, 2025. That was up 1.1% from $1.13B in fiscal 2024. United States was the largest at $897.54M (78.9%), ahead of Rest Of World at $240.22M (21.1%).
Compared with fiscal 2024, United States grew 1.2% to $897.54M and Rest Of World grew 0.6% to $240.22M. From fiscal 2022 to 2025, combined revenue from these regions grew from $1.09B to $1.14B, a compound annual growth rate of 1.5%. United States' share of the total fell from 83.7% to 78.9%.
Prestige Consumer Healthcare (PBH) reports its revenue by product and service, by segment and by geography. In fiscal 2025, Gastrointestinal was its largest product and service line, bringing in $255.94M (22.5% of the total), followed by Women's Health at $236.83M (20.8%).
Gastrointestinal was Prestige Consumer Healthcare's largest product and service line in fiscal 2025, bringing in $255.94M, or 22.5% of the $1.14B total across its eight product and service lines.
North American Otc Healthcare was Prestige Consumer Healthcare's largest segment in fiscal 2025, bringing in $960.01M, or 84.4% of the $1.14B total across its two segments.
United States was Prestige Consumer Healthcare's largest region in fiscal 2025, bringing in $897.54M, or 78.9% of the $1.14B total across its two regions.
International Otc Healthcare grew faster than North American Otc Healthcare in fiscal 2025, up 6.4% from $167.10M to $177.75M. North American Otc Healthcare grew 0.2% to $960.01M.
Every figure comes from Prestige Consumer Healthcare's annual financial filings, as reported. Each line keeps the name Prestige Consumer Healthcare gives it, and years follow its fiscal calendar.
Prestige Consumer Healthcare's revenue by product and service goes back to fiscal 2013, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.